Pulmonary Valve Replacement Market
Pulmonary Valve Replacement Market Forecasts to 2030 - Global Analysis By Valve Type (Tissue Engineered Pulmonary Valves, Bioprosthetic Pulmonary Valves, Homograft Pulmonary Valves, Mechanical Pulmonary Valves and Other Valve Types), Procedure Type, Application, End User, and By Geography
According to Stratistics MRC, the Global Pulmonary Valve Replacement Market is accounted for $1.2 billion in 2023 and is expected to reach $2.0 billion by 2030 growing at a CAGR of 7.1% during the forecast period. Pulmonary valve replacement (PVR) is a surgical procedure aimed at replacing a defective or damaged pulmonary valve in the heart. The pulmonary valve regulates blood flow from the heart's right ventricle to the pulmonary artery, facilitating oxygenation of blood in the lungs. Surgeons typically use either mechanical or biological prosthetic valves to restore proper cardiac function. PVR can alleviate symptoms like shortness of breath, chest pain, and fatigue, improving overall heart health and quality of life. Post-operative care involves monitoring for complications and cardiac rehabilitation to support recovery and long-term well-being.
Market Dynamics:
Driver:
Increasing healthcare expenditure
As healthcare spending rises, particularly in emerging economies and developed countries, there is a corresponding increase in access to specialized cardiac care procedures. This improved infrastructure enables healthcare providers to offer a wider range of treatment options to a greater number of patients. Moreover, increased healthcare spending often correlates with improvements in insurance coverage and reimbursement policies, reducing financial barriers for patients, which drives this market growth.
Restraint:
High cost
The complexity and invasiveness of the procedure are two of the primary factors contributing to the high cost of pulmonary valve replacement. These factors contribute to the overall cost of the procedure, including pre-operative assessments, post-operative care, and follow-up visits. Additionally, the materials used in pulmonary valve replacement, such as prosthetic valves or conduits, can be expensive, further driving up the cost of the procedure.
Opportunity:
Technological advancements
Advancements in prosthetic valve design and materials contribute to improved longevity, durability, and biocompatibility of pulmonary valve replacements. These innovations result in better clinical outcomes and reduced rates of valve failure, leading to increased patient satisfaction and a decreased need for repeat interventions. Furthermore, advancements in imaging technologies, such as 3D echocardiography and cardiac magnetic resonance imaging (MRI), enhance preoperative planning, which is boosting this market growth.
Threat:
Lack of awareness
Limited awareness about the symptoms and consequences of pulmonary valve conditions may lead to delays in diagnosis and intervention, resulting in poorer patient outcomes. Healthcare providers may also lack sufficient understanding of the latest advancements in techniques and technologies, leading to suboptimal patient care and the underutilization of appropriate treatments. Furthermore, patients and their families may have misconceptions or fears about surgical procedures, which can impede this market size.
Covid-19 Impact
The COVID-19 pandemic has significantly impacted the pulmonary valve replacement market. As healthcare systems worldwide diverted resources to manage the pandemic, elective procedures, including pulmonary valve replacements, experienced delays and cancellations. This led to a reduction in procedural volumes and revenue for manufacturers and healthcare facilities specializing in cardiac interventions. Moreover, patient reluctance to seek non-urgent medical care due to fear of exposure to the virus further dampened demand for pulmonary valve replacement procedures.
The tissue engineered pulmonary valves segment is expected to be the largest during the forecast period
The tissue engineered pulmonary valves segment is estimated to hold the largest share. These valves are designed to mimic the structure and function of native pulmonary valves, offering promising solutions for patients with pulmonary valve dysfunction. Tissue-engineered pulmonary valves are typically created by seeding cells onto a biodegradable scaffold, allowing for the growth of living tissue. Additionally, tissue-engineered valves have shown promising outcomes in terms of long-term functionality and hemodynamic performance, which gradually boosts this segment’s growth.
The transcatheter pulmonary valve replacement (TPVR) segment is expected to have the highest CAGR during the forecast period
The transcatheter pulmonary valve replacement (TPVR) segment is anticipated to have highest CAGR during the forecast period due to its minimally invasive procedure for replacing pulmonary valves via catheterization. This approach is particularly beneficial for patients with congenital heart defects, pulmonary valve stenosis, or regurgitation. Furthermore, TPVR procedures have demonstrated excellent outcomes in terms of safety, efficacy, and patient recovery, compared to traditional surgical interventions, which are driving this segment’s expansion.
Region with largest share:
North America commanded the largest market share during the extrapolated period owing to a growing prevalence of congenital heart diseases and valve disorders. This region is home to some of the major players, such as Medtronic, Abbott Laboratories, and Boston Scientific. Moreover, government initiatives aimed at improving cardiovascular healthcare and advancing medical research also play a vital role in fueling market growth.
Region with highest CAGR:
Europe is expected to witness highest CAGR over the projection period, owing to significant advancements in medical technology, robust healthcare systems. Countries like Germany, France, the United Kingdom, and Italy are key contributors to the market's growth in the region. Additionally, Europe has a strong regulatory framework supporting medical innovation, ensuring the safety and efficacy of new pulmonary valve replacement technologies, fostering competition, and driving advancements in the field.
Key players in the market
Some of the key players in the Pulmonary Valve Replacement Market include Edwards Lifesciences, Medtronic, Terumo Corporation, CryoLife, Inc, SynCardia Systems, Inc., Abbott Laboratories, Merit Medical Systems, LivaNova PLC, Micro Interventional Devices, Inc., Boston Scientific, Braile Biomedica, JenaValve Technology, Inc., B. Braun Melsungen AG, Medistim and CardioMech AS.
Key Developments:
In January 2024, Boston Scientific Corporation announced it has entered into a definitive agreement to acquire Axonics, Inc., a publicly traded medical technology company primarily focused on the development and commercialization of differentiated devices to treat urinary and bowel dysfunction.
In December 2023, Medtronic plc announced that it has entered into a definitive agreement to expand its partnership with Cosmo Intelligent Medical Devices, a subsidiary of Cosmo Pharmaceuticals.
In November 2023, Medtronic plc announced that the United States Food and Drug Administration (FDA) has approved the Symplicity Spyral™ renal denervation (RDN) system, also known as the Symplicity™ blood pressure procedure, for the treatment of hypertension.
In September 2023, Boston Scientific Corporation announced it has received U.S. Food and Drug Administration approval for the latest-generation WATCHMAN FLX™ Pro Left Atrial Appendage Closure (LAAC) Device.
Valve Types Covered:
• Tissue Engineered Pulmonary Valves
• Bioprosthetic Pulmonary Valves
• Homograft Pulmonary Valves
• Mechanical Pulmonary Valves
• Other Valve Types
Procedure Types Covered:
• Transcatheter Pulmonary Valve Replacement (TPVR)
• Surgical Pulmonary Valve Replacement (Open-heart surgery)
• Robotic-Assisted Pulmonary Valve Replacement
• Ross Procedure
• Valvulotomy
• Other Procedure Types
Applications Covered:
• Pulmonary Stenosis
• Valve Dysfunction
• Congenital Heart Defects
• Pulmonary Regurgitation
• Other Applications
End Users Covered:
• Ambulatory Surgical Centers
• Hospitals
• Cardiac Specialty Clinics
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Pulmonary Valve Replacement Market, By Valve Type
5.1 Introduction
5.2 Tissue Engineered Pulmonary Valves
5.3 Bioprosthetic Pulmonary Valves
5.4 Homograft Pulmonary Valves
5.5 Mechanical Pulmonary Valves
5.6 Other Valve Types
6 Global Pulmonary Valve Replacement Market, By Procedure Type
6.1 Introduction
6.2 Transcatheter Pulmonary Valve Replacement (TPVR)
6.3 Surgical Pulmonary Valve Replacement (Open-heart surgery)
6.4 Robotic-Assisted Pulmonary Valve Replacement
6.5 Ross Procedure
6.6 Valvulotomy
6.7 Other Procedure Types
7 Global Pulmonary Valve Replacement Market, By Application
7.1 Introduction
7.2 Pulmonary Stenosis
7.3 Valve Dysfunction
7.4 Congenital Heart Defects
7.5 Pulmonary Regurgitation
7.6 Other Applications
8 Global Pulmonary Valve Replacement Market, By End User
8.1 Introduction
8.2 Ambulatory Surgical Centers
8.3 Hospitals
8.4 Cardiac Specialty Clinics
8.5 Other End Users
9 Global Pulmonary Valve Replacement Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Edwards Lifesciences
11.2 Medtronic
11.3 Terumo Corporation
11.4 CryoLife, Inc
11.5 SynCardia Systems, Inc.
11.6 Abbott Laboratories
11.7 Merit Medical Systems
11.8 LivaNova PLC
11.9 Micro Interventional Devices, Inc.
11.10 Boston Scientific
11.11 Braile Biomedica
11.12 JenaValve Technology, Inc.
11.13 B. Braun Melsungen AG
11.14 Medistim
11.15 CardioMech AS
List of Tables
1 Global Pulmonary Valve Replacement Market Outlook, By Region (2021-2030) ($MN)
2 Global Pulmonary Valve Replacement Market Outlook, By Valve Type (2021-2030) ($MN)
3 Global Pulmonary Valve Replacement Market Outlook, By Tissue Engineered Pulmonary Valves (2021-2030) ($MN)
4 Global Pulmonary Valve Replacement Market Outlook, By Bioprosthetic Pulmonary Valves (2021-2030) ($MN)
5 Global Pulmonary Valve Replacement Market Outlook, By Homograft Pulmonary Valves (2021-2030) ($MN)
6 Global Pulmonary Valve Replacement Market Outlook, By Mechanical Pulmonary Valves (2021-2030) ($MN)
7 Global Pulmonary Valve Replacement Market Outlook, By Other Valve Types (2021-2030) ($MN)
8 Global Pulmonary Valve Replacement Market Outlook, By Procedure Type (2021-2030) ($MN)
9 Global Pulmonary Valve Replacement Market Outlook, By Transcatheter Pulmonary Valve Replacement (TPVR) (2021-2030) ($MN)
10 Global Pulmonary Valve Replacement Market Outlook, By Surgical Pulmonary Valve Replacement (Open-heart surgery) (2021-2030) ($MN)
11 Global Pulmonary Valve Replacement Market Outlook, By Robotic-Assisted Pulmonary Valve Replacement (2021-2030) ($MN)
12 Global Pulmonary Valve Replacement Market Outlook, By Ross Procedure (2021-2030) ($MN)
13 Global Pulmonary Valve Replacement Market Outlook, By Valvulotomy (2021-2030) ($MN)
14 Global Pulmonary Valve Replacement Market Outlook, By Other Procedure Types (2021-2030) ($MN)
15 Global Pulmonary Valve Replacement Market Outlook, By Application (2021-2030) ($MN)
16 Global Pulmonary Valve Replacement Market Outlook, By Pulmonary Stenosis (2021-2030) ($MN)
17 Global Pulmonary Valve Replacement Market Outlook, By Valve Dysfunction (2021-2030) ($MN)
18 Global Pulmonary Valve Replacement Market Outlook, By Congenital Heart Defects (2021-2030) ($MN)
19 Global Pulmonary Valve Replacement Market Outlook, By Pulmonary Regurgitation (2021-2030) ($MN)
20 Global Pulmonary Valve Replacement Market Outlook, By Other Applications (2021-2030) ($MN)
21 Global Pulmonary Valve Replacement Market Outlook, By End User (2021-2030) ($MN)
22 Global Pulmonary Valve Replacement Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
23 Global Pulmonary Valve Replacement Market Outlook, By Hospitals (2021-2030) ($MN)
24 Global Pulmonary Valve Replacement Market Outlook, By Cardiac Specialty Clinics (2021-2030) ($MN)
25 Global Pulmonary Valve Replacement Market Outlook, By Other End Users (2021-2030) ($MN)
26 North America Pulmonary Valve Replacement Market Outlook, By Country (2021-2030) ($MN)
27 North America Pulmonary Valve Replacement Market Outlook, By Valve Type (2021-2030) ($MN)
28 North America Pulmonary Valve Replacement Market Outlook, By Tissue Engineered Pulmonary Valves (2021-2030) ($MN)
29 North America Pulmonary Valve Replacement Market Outlook, By Bioprosthetic Pulmonary Valves (2021-2030) ($MN)
30 North America Pulmonary Valve Replacement Market Outlook, By Homograft Pulmonary Valves (2021-2030) ($MN)
31 North America Pulmonary Valve Replacement Market Outlook, By Mechanical Pulmonary Valves (2021-2030) ($MN)
32 North America Pulmonary Valve Replacement Market Outlook, By Other Valve Types (2021-2030) ($MN)
33 North America Pulmonary Valve Replacement Market Outlook, By Procedure Type (2021-2030) ($MN)
34 North America Pulmonary Valve Replacement Market Outlook, By Transcatheter Pulmonary Valve Replacement (TPVR) (2021-2030) ($MN)
35 North America Pulmonary Valve Replacement Market Outlook, By Surgical Pulmonary Valve Replacement (Open-heart surgery) (2021-2030) ($MN)
36 North America Pulmonary Valve Replacement Market Outlook, By Robotic-Assisted Pulmonary Valve Replacement (2021-2030) ($MN)
37 North America Pulmonary Valve Replacement Market Outlook, By Ross Procedure (2021-2030) ($MN)
38 North America Pulmonary Valve Replacement Market Outlook, By Valvulotomy (2021-2030) ($MN)
39 North America Pulmonary Valve Replacement Market Outlook, By Other Procedure Types (2021-2030) ($MN)
40 North America Pulmonary Valve Replacement Market Outlook, By Application (2021-2030) ($MN)
41 North America Pulmonary Valve Replacement Market Outlook, By Pulmonary Stenosis (2021-2030) ($MN)
42 North America Pulmonary Valve Replacement Market Outlook, By Valve Dysfunction (2021-2030) ($MN)
43 North America Pulmonary Valve Replacement Market Outlook, By Congenital Heart Defects (2021-2030) ($MN)
44 North America Pulmonary Valve Replacement Market Outlook, By Pulmonary Regurgitation (2021-2030) ($MN)
45 North America Pulmonary Valve Replacement Market Outlook, By Other Applications (2021-2030) ($MN)
46 North America Pulmonary Valve Replacement Market Outlook, By End User (2021-2030) ($MN)
47 North America Pulmonary Valve Replacement Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
48 North America Pulmonary Valve Replacement Market Outlook, By Hospitals (2021-2030) ($MN)
49 North America Pulmonary Valve Replacement Market Outlook, By Cardiac Specialty Clinics (2021-2030) ($MN)
50 North America Pulmonary Valve Replacement Market Outlook, By Other End Users (2021-2030) ($MN)
51 Europe Pulmonary Valve Replacement Market Outlook, By Country (2021-2030) ($MN)
52 Europe Pulmonary Valve Replacement Market Outlook, By Valve Type (2021-2030) ($MN)
53 Europe Pulmonary Valve Replacement Market Outlook, By Tissue Engineered Pulmonary Valves (2021-2030) ($MN)
54 Europe Pulmonary Valve Replacement Market Outlook, By Bioprosthetic Pulmonary Valves (2021-2030) ($MN)
55 Europe Pulmonary Valve Replacement Market Outlook, By Homograft Pulmonary Valves (2021-2030) ($MN)
56 Europe Pulmonary Valve Replacement Market Outlook, By Mechanical Pulmonary Valves (2021-2030) ($MN)
57 Europe Pulmonary Valve Replacement Market Outlook, By Other Valve Types (2021-2030) ($MN)
58 Europe Pulmonary Valve Replacement Market Outlook, By Procedure Type (2021-2030) ($MN)
59 Europe Pulmonary Valve Replacement Market Outlook, By Transcatheter Pulmonary Valve Replacement (TPVR) (2021-2030) ($MN)
60 Europe Pulmonary Valve Replacement Market Outlook, By Surgical Pulmonary Valve Replacement (Open-heart surgery) (2021-2030) ($MN)
61 Europe Pulmonary Valve Replacement Market Outlook, By Robotic-Assisted Pulmonary Valve Replacement (2021-2030) ($MN)
62 Europe Pulmonary Valve Replacement Market Outlook, By Ross Procedure (2021-2030) ($MN)
63 Europe Pulmonary Valve Replacement Market Outlook, By Valvulotomy (2021-2030) ($MN)
64 Europe Pulmonary Valve Replacement Market Outlook, By Other Procedure Types (2021-2030) ($MN)
65 Europe Pulmonary Valve Replacement Market Outlook, By Application (2021-2030) ($MN)
66 Europe Pulmonary Valve Replacement Market Outlook, By Pulmonary Stenosis (2021-2030) ($MN)
67 Europe Pulmonary Valve Replacement Market Outlook, By Valve Dysfunction (2021-2030) ($MN)
68 Europe Pulmonary Valve Replacement Market Outlook, By Congenital Heart Defects (2021-2030) ($MN)
69 Europe Pulmonary Valve Replacement Market Outlook, By Pulmonary Regurgitation (2021-2030) ($MN)
70 Europe Pulmonary Valve Replacement Market Outlook, By Other Applications (2021-2030) ($MN)
71 Europe Pulmonary Valve Replacement Market Outlook, By End User (2021-2030) ($MN)
72 Europe Pulmonary Valve Replacement Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
73 Europe Pulmonary Valve Replacement Market Outlook, By Hospitals (2021-2030) ($MN)
74 Europe Pulmonary Valve Replacement Market Outlook, By Cardiac Specialty Clinics (2021-2030) ($MN)
75 Europe Pulmonary Valve Replacement Market Outlook, By Other End Users (2021-2030) ($MN)
76 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Country (2021-2030) ($MN)
77 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Valve Type (2021-2030) ($MN)
78 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Tissue Engineered Pulmonary Valves (2021-2030) ($MN)
79 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Bioprosthetic Pulmonary Valves (2021-2030) ($MN)
80 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Homograft Pulmonary Valves (2021-2030) ($MN)
81 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Mechanical Pulmonary Valves (2021-2030) ($MN)
82 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Other Valve Types (2021-2030) ($MN)
83 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Procedure Type (2021-2030) ($MN)
84 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Transcatheter Pulmonary Valve Replacement (TPVR) (2021-2030) ($MN)
85 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Surgical Pulmonary Valve Replacement (Open-heart surgery) (2021-2030) ($MN)
86 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Robotic-Assisted Pulmonary Valve Replacement (2021-2030) ($MN)
87 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Ross Procedure (2021-2030) ($MN)
88 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Valvulotomy (2021-2030) ($MN)
89 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Other Procedure Types (2021-2030) ($MN)
90 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Application (2021-2030) ($MN)
91 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Pulmonary Stenosis (2021-2030) ($MN)
92 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Valve Dysfunction (2021-2030) ($MN)
93 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Congenital Heart Defects (2021-2030) ($MN)
94 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Pulmonary Regurgitation (2021-2030) ($MN)
95 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Other Applications (2021-2030) ($MN)
96 Asia Pacific Pulmonary Valve Replacement Market Outlook, By End User (2021-2030) ($MN)
97 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
98 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Hospitals (2021-2030) ($MN)
99 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Cardiac Specialty Clinics (2021-2030) ($MN)
100 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Other End Users (2021-2030) ($MN)
101 South America Pulmonary Valve Replacement Market Outlook, By Country (2021-2030) ($MN)
102 South America Pulmonary Valve Replacement Market Outlook, By Valve Type (2021-2030) ($MN)
103 South America Pulmonary Valve Replacement Market Outlook, By Tissue Engineered Pulmonary Valves (2021-2030) ($MN)
104 South America Pulmonary Valve Replacement Market Outlook, By Bioprosthetic Pulmonary Valves (2021-2030) ($MN)
105 South America Pulmonary Valve Replacement Market Outlook, By Homograft Pulmonary Valves (2021-2030) ($MN)
106 South America Pulmonary Valve Replacement Market Outlook, By Mechanical Pulmonary Valves (2021-2030) ($MN)
107 South America Pulmonary Valve Replacement Market Outlook, By Other Valve Types (2021-2030) ($MN)
108 South America Pulmonary Valve Replacement Market Outlook, By Procedure Type (2021-2030) ($MN)
109 South America Pulmonary Valve Replacement Market Outlook, By Transcatheter Pulmonary Valve Replacement (TPVR) (2021-2030) ($MN)
110 South America Pulmonary Valve Replacement Market Outlook, By Surgical Pulmonary Valve Replacement (Open-heart surgery) (2021-2030) ($MN)
111 South America Pulmonary Valve Replacement Market Outlook, By Robotic-Assisted Pulmonary Valve Replacement (2021-2030) ($MN)
112 South America Pulmonary Valve Replacement Market Outlook, By Ross Procedure (2021-2030) ($MN)
113 South America Pulmonary Valve Replacement Market Outlook, By Valvulotomy (2021-2030) ($MN)
114 South America Pulmonary Valve Replacement Market Outlook, By Other Procedure Types (2021-2030) ($MN)
115 South America Pulmonary Valve Replacement Market Outlook, By Application (2021-2030) ($MN)
116 South America Pulmonary Valve Replacement Market Outlook, By Pulmonary Stenosis (2021-2030) ($MN)
117 South America Pulmonary Valve Replacement Market Outlook, By Valve Dysfunction (2021-2030) ($MN)
118 South America Pulmonary Valve Replacement Market Outlook, By Congenital Heart Defects (2021-2030) ($MN)
119 South America Pulmonary Valve Replacement Market Outlook, By Pulmonary Regurgitation (2021-2030) ($MN)
120 South America Pulmonary Valve Replacement Market Outlook, By Other Applications (2021-2030) ($MN)
121 South America Pulmonary Valve Replacement Market Outlook, By End User (2021-2030) ($MN)
122 South America Pulmonary Valve Replacement Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
123 South America Pulmonary Valve Replacement Market Outlook, By Hospitals (2021-2030) ($MN)
124 South America Pulmonary Valve Replacement Market Outlook, By Cardiac Specialty Clinics (2021-2030) ($MN)
125 South America Pulmonary Valve Replacement Market Outlook, By Other End Users (2021-2030) ($MN)
126 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Country (2021-2030) ($MN)
127 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Valve Type (2021-2030) ($MN)
128 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Tissue Engineered Pulmonary Valves (2021-2030) ($MN)
129 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Bioprosthetic Pulmonary Valves (2021-2030) ($MN)
130 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Homograft Pulmonary Valves (2021-2030) ($MN)
131 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Mechanical Pulmonary Valves (2021-2030) ($MN)
132 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Other Valve Types (2021-2030) ($MN)
133 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Procedure Type (2021-2030) ($MN)
134 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Transcatheter Pulmonary Valve Replacement (TPVR) (2021-2030) ($MN)
135 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Surgical Pulmonary Valve Replacement (Open-heart surgery) (2021-2030) ($MN)
136 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Robotic-Assisted Pulmonary Valve Replacement (2021-2030) ($MN)
137 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Ross Procedure (2021-2030) ($MN)
138 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Valvulotomy (2021-2030) ($MN)
139 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Other Procedure Types (2021-2030) ($MN)
140 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Application (2021-2030) ($MN)
141 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Pulmonary Stenosis (2021-2030) ($MN)
142 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Valve Dysfunction (2021-2030) ($MN)
143 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Congenital Heart Defects (2021-2030) ($MN)
144 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Pulmonary Regurgitation (2021-2030) ($MN)
145 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Other Applications (2021-2030) ($MN)
146 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By End User (2021-2030) ($MN)
147 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
148 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Hospitals (2021-2030) ($MN)
149 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Cardiac Specialty Clinics (2021-2030) ($MN)
150 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Other End Users (2021-2030) ($MN)
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
